MindMed
A psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Learn more
Launch date
Employees
Market cap
AUD812m
Enterprise valuation
AUD473m (Public information from Sep 2024)
Share price
$6.31 MNMD
New York City New York (HQ)
Authorizing premium user...